Griffith, M. et al. Genome modeling system: a knowledge management platform for genomics. PLoS Comput. Biol. 11, e1004274 (2015).
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
Robinson, J. T., Thorvaldsdóttir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the integrative genomics viewer. Cancer Res. 77, e31–e34 (2017).
Li, M. M. et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J. Mol. Diagn. 19, 4–23 (2017).
Roy, S. et al. Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College of American Pathologists. J. Mol. Diagn. 20, 4–27 (2017).
Rheinbay, E. et al. Recurrent and functional regulatory mutations in breast cancer. Nature 547, 55–60 (2017).
Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217–221 (2017).
Ma, C. X. et al. A phase I trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor-positive metastatic breast cancer. Clin. Cancer Res. 22, 1583–1591 (2016).
The Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481–2498 (2015).
Rasche, L. et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat. Commun. 8, 268 (2017).
Barnell, E. K. et al. Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples. Genet. Med. https://doi.org/10.1038/s41436-018-0278-z (2018).
Griffith, O. L. et al. Truncating prolactin receptor mutations promote tumor growth in murine estrogen receptor-alpha mammary carcinomas. Cell Rep. 17, 249–260 (2016).
Koboldt, D. C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283–2285 (2009).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865–2871 (2009).
Simola, D. F. & Kim, J. Sniper: improved SNP discovery by multiply mapping deep sequenced reads. Genome. Biol. 12, R55 (2011).
Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811–1817 (2012).
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
Ding, J. et al. Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data. Bioinformatics 28, 167–175 (2012).
Spinella, J.-F. et al. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing. BMC Genomics 17, 912 (2016).
Strom, S. P. Current practices and guidelines for clinical next-generation sequencing oncology testing. Cancer Biol. Med. 13, 3–11 (2016).
Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, 224ra24 (2014).
McHugh, M. L. Interrater reliability: the kappa statistic. Biochem. Med. 22, 276–282 (2012).
Griffith, M. et al. Optimizing cancer genome sequencing and analysis. Cell Syst. 1, 210–223 (2015).
Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271–281.e7 (2018).
Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat. Genet. 49, 170–174 (2017).
Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41, e67 (2013).
Swamidass, S. J., Bittker, J. A., Bodycombe, N. E., Ryder, S. P. & Clemons, P. A. An economic framework to prioritize confirmatory tests after a high-throughput screen. J. Biomol. Screen. 15, 680–686 (2010).
Settles, B. & Craven, M. An analysis of active learning strategies for sequence labeling tasks. In Proceedings of the Conference on Empirical Methods in Natural Language Processing - EMNLP ’08, https://doi.org/10.3115/1613715.1613855 (Association for Computational Linguistics, Stroudsburg, PA, USA; 2008).
Settles, B. in Synthesis Lectures on Artificial Intelligence and Machine Learning Vol. 6 1–114 (Morgan & Claypool, San Rafael, 2012).
Griffith, M. et al. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia. Exp. Hematol. 44, 603–613 (2016).
Krysiak, K. et al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood 129, 473–483 (2017).
Klco, J. M. et al. Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia. JAMA 314, 811–822 (2015).
Uy, G. L. et al. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy. Leukemia 31, 872–881 (2017).
Lesurf, R. et al. Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Ann. Oncol. 28, 1070–1077 (2017).
Welch, J. S. et al. TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes. N. Engl. J. Med. 375, 2023–2036 (2016).
Rohan, T. E. et al. Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer. Br. J. Cancer 118, 1662–1664 (2018).
Mahlokozera, T. et al. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma. Neuro. Oncol. 20, 472–483 (2018).
Wagner, A. H. et al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.Nat. Commun. 9, 3787 (2018).
Duncavage, E. J. et al. Mutation clearance after transplantation for myelodysplastic syndrome. N. Engl. J. Med. 379, 1028–1041 (2018).
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https://arxiv.org/abs/1303.3997 (2013).
Picard Tools (Broad Institute, 2018); http://broadinstitute.github.io/picard/
Varoquaux, G. et al. Scikit-learn: machine learning without learning the machinery. GetMobile 19, 29–33 (2015).
Nelli, F. Machine Learning with scikit-learn. In Python Data Analytics 2nd edn, Ch. 7 237–264 (Apress, New York, 2015).
Oliphant, T. E. Python for scientific computing. Comput. Sci. Eng. 9, 10–20 (2007).
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
Grüning, B. et al. Bioconda: sustainable and comprehensive software distribution for the life sciences. Nat. Methods 15, 475–476 (2018).